How each document records taste
Zepbound®’s main US safety table only lists reactions seen in at least 2% of people on Zepbound® and more often than with placebo. Dysgeusia falls well below that, so the label reports it in a short paragraph of section 6.1: 0.4% on Zepbound® against none on placebo, in the pooled SURMOUNT-1 and SURMOUNT-2 trials. [1] Canada, which uses a 1% threshold for its main table, places dysgeusia in a separate list of less common trial reactions. [3]
| Source | What it says | Rate |
|---|---|---|
| US label §6.1, SURMOUNT-1 and -2 [1] | Dysgeusia | 0.4% Zepbound® vs 0% placebo |
| Canadian monograph §8.3 [3] | Dysgeusia among less common clinical trial reactions | Below 1%; no figure given |
| Canadian patient information [3] | “Change in taste” among possible side effects | — |
| EU, tirzepatide sold as Mounjaro® [4] | Dysgeusia (patient leaflet: changed sense of taste) | Uncommon (1 in 1,000 to 1 in 100) |
| US Medication Guide [2] | Not named among most common side effects | — |
What research adds
No trial has been designed to measure taste on tirzepatide. A large analysis of FDA spontaneous reports for six GLP-1 medicines, including tirzepatide, identified dysgeusia, taste disorder and parosmia, a distorted sense of smell, among nervous-system signals, with reports often starting within about a month of treatment. [5] A 2026 review of oral effects of these medicines lists dysgeusia among reported problems, alongside dry mouth and burning sensations, and notes that the evidence is limited and largely indirect. [6]
Taste and appetite are easy to confuse. A 2025 review of how GLP-1 medicines, including tirzepatide, change food preferences found that most studies relied on people’s own reports and measured the weight-loss phase only. [7] A tirzepatide-specific analysis of FDA reports found new signals for hunger and food craving, [8] which shows how varied people’s experiences of eating can be. These reports describe association, not cause.
Why food might taste different
There are several explanations, at different levels of certainty.
- Recorded for Zepbound®: dysgeusia itself, at a low rate, [1] and dry mouth at 1% versus 0.1%. [1] MedlinePlus lists mouth dryness among causes of impaired taste. [9]
- Plausible but not proven: reduced saliva from signalling changes in the salivary glands, or dehydration after vomiting or diarrhea, two routes proposed in the oral-effects review. [6] Nausea, reflux and burping, all more common on Zepbound® than placebo, can also leave an unpleasant taste. [1]
- Diet-related: tirzepatide reduces calorie intake, [1] and a small 2026 study of people starting semaglutide or tirzepatide found intake of several micronutrients fell over 24 weeks. [11] MedlinePlus names vitamin B12 and zinc deficiency among causes of taste problems, [9] though no study has linked these to taste changes on Zepbound®.
Causes unrelated to the injection
MedlinePlus lists colds, flu and other viral infections, sinus problems and nasal polyps, throat infections, gum disease, heavy smoking, head injury and some ear or sinus surgery among causes of taste impairment, along with certain medicines, including some thyroid medicines, some antibiotics and lithium. [9] The National Institute on Deafness and Other Communication Disorders adds that most people who believe they have lost taste actually have a smell problem, because flavour depends heavily on aroma. [10]
Age matters as well: taste often fades after 60, with salty and sweet usually affected first. [9] A new medicine started around the same time as Zepbound®, or a recent cold, is often the simpler explanation.
Practical points from health agencies
Zepbound®’s Medication Guide has no taste-specific advice; it asks you to report side effects that bother you or do not go away. [2] The NIH suggests aromatic herbs and spices to add flavour without extra sugar or salt, and avoiding mixed dishes such as casseroles that blur individual flavours. [10] It also warns that a weaker sense of taste can lead people to add sugar or salt, which matters for people with diabetes or high blood pressure. [10]
If a medicine is a likely cause, the NIH notes that changing it may help, but only when your doctor directs it. [10] Persistent taste problems are usually assessed by an ear, nose and throat specialist, including a dental check and a taste test. [10] Ask your pharmacist before trying zinc or other supplements, since Zepbound® can change how some oral medicines are absorbed. [1]
Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
The signs and contact information below come from this article’s sourced guidance.
Emergency
- Swelling of the lips, tongue or throat, or trouble breathing or swallowing
Contact: Stop Zepbound® and get emergency help (911 or local number)
Medication Guide [2]